Listing & Compliance Notices

RELMADA THERAPEUTICS, INC. received a nasdaq extension granted notice regarding minimum bid price (rules 5550(a)(2)).

“July 22, 2025, Nasdaq notified the Company that it had approved the Company’s application to transfer its listing to the Nasdaq Capital Market. The Company’s securities will be transferred to the Nasdaq Capital Market at the opening of business on July 24, 2025. Nasdaq also approved a 180-day extension, or until January 19, 2026 (the “Compliance Period”), to regain compliance with the minimum bid price in accordance with Nasdaq Listing Rule 5550(a)(2). To regain compliance, the Company’s common stock must maintain a closing bid price of at least $1.00 per share for a minimum of 10 consecutive”

RELMADA THERAPEUTICS, INC. received a nasdaq deficiency notice notice regarding minimum bid price (rules 5810(c)(3)(A)).

“January 21, 2025, Relmada Therapeutics, Inc. (the “Company”) received a written notification from the Listing Qualifications Department of the Nasdaq Stock Market (“Nasdaq”) notifying the Company that, for the 30 consecutive business days ended January 17, 2025, the Company’s security did not maintain a minimum bid price of $1 per share. Nasdaq stated in its letter that in accordance with Nasdaq Listing Rule 5810(c)(3)(A), the Company had a compliance period of 180 calendar days from the date of the notice (“Initial Compliance Period”), and that it may regain compliance if the closing bid of t”

Rocky Mountain Chocolate Factory, Inc. received a nasdaq noncompliance notice notice regarding stockholders equity (rules 5450(b)(1)(A)).

“January 21, 2025, Rocky Mountain Chocolate Factory, Inc. (the “Company”) was notified by the Nasdaq Stock Market LLC (“Nasdaq”) that the Company was not in compliance with the minimum stockholders’ equity requirement for continued listing on The Nasdaq Global Market under Nasdaq Listing Rule 5450(b)(1)(A) (the “Rule”). The Rule requires companies listed on The Nasdaq Global Market to maintain stockholders’ equity of at least $10,000,000. On July 22, 2025, Nasdaq notified the Company that it had approved the Company’s voluntary application to transfer its listing from The Nasdaq Global Market t”

Ocean Biomedical, Inc. received a nasdaq delisting notice notice.

“April 22, 2025, the Nasdaq Hearings Panel (the “Panel”) issued a decision to delist the Company’s securities from The Nasdaq Stock Market, LLC (the “Exchange” or “Nasdaq”) and suspend trading of the Company’s shares, effective at the opening of business on April 24, 2025. The Company appealed the Panel’s decision to the Listing Council. After considering the written record in this matter, the Listing Council affirms the Panel’s decision to delist the Company from the Nasdaq affirming Nasdaq’s delist decision letter dated April 22, 2025. SIGNATURE Pursuant to the requirements of the Securities”

INTERGROUP CORP received a nasdaq hearing update notice regarding market value (rules 5550(b)(2)).

“July 17, 2025, the Panel notified the Company that it had granted an extension to regain compliance. The Company must demonstrate compliance with the Rule by having a market value of listed securities of at least $35 million for ten consecutive trading days on or before September 30, 2025. Management Actions to Regain Compliance In connection with its ongoing efforts to regain compliance with Nasdaq Listing Rule 5550(b)(2), management is actively pursuing initiatives intended to enhance market visibility and shareholder value. These efforts include, but are not limited to, efforts to communica”

INTERGROUP CORP received a nasdaq deficiency notice notice regarding market value (rules 5550(b)(2), 5810(c)(3)(C)).

“November 21, 2024, Nasdaq Listing Qualifications Department (the “Staff”) notified The InterGroup Corporation (the “Company”) that the market value of its listed securities had been below the minimum $35,000,000 required for continued listing as set forth in Listing Rule 5550(b)(2) (the “Rule”) for the previous 30 consecutive trading days. Under Listing Rule 5810(c)(3)(C), the Company was provided 180 calendar days, or until May 20, 2025, to regain compliance with the Rule. As the Company did not meet the compliance criteria by that date, it was subsequently notified by the Staff on May 27, 20”

QUANTUM CORP /DE/ received a nasdaq noncompliance notice notice regarding late filing (rules 5250(c)(1)).

“July 17, 2025, Quantum Corporation (the “Company”) received a written notice (the “Notice”) from the Listing Qualifications staff of the Nasdaq Stock Market LLC (“Nasdaq”) stating that the Company is not in compliance with Nasdaq Listing Rule 5250(c)(1) as a result of the Company’s failure to timely file its Annual Report on Form 10-K for the fiscal year ended March 31, 2025 (the “Annual Report”) with the Securities and Exchange Commission (the “SEC”). On June 30, 2025, the Company filed a Notification of Late Filing on Form 12b-25 with the SEC indicating that the Annual Report would be delaye”

SUI Group Holdings Ltd. received a nasdaq noncompliance notice notice regarding audit committee (rules 5605(b)(1), 5605(c)(2), 5605(b)(1)(A), 5605(c)(4)).

“July 18, 2025, the Company received a letter from Nasdaq indicating that, due to Mr. Zipkin’s death, the Company no longer complies with Nasdaq Listing Rule 5605(b)(1), which requires that a majority of the Board of Directors of the Company consist of “independent directors” as defined by Nasdaq Listing Rule 5605(a)(2), and Nasdaq Listing Rule 5605(c)(2), which requires that the Audit Committee consist of at least three “independent directors.” In accordance with Nasdaq Listing Rules 5605(b)(1)(A) and 5605(c)(4), the Company must cure these deficiencies and evidence compliance prior to (a) its”

UNIVERSAL SAFETY PRODUCTS, INC. received a nyse_american noncompliance notice notice regarding late filing (rules 1007).

“nual Report on Form 10-K for the year ended March 31, 2025 with the Securities and Exchange Commission (the “SEC”). The Delinquency Notification also states that the Company’s failure to timely file such Annual Report on Form 10-K subjects the Company to the procedures and requirements set forth in Section 1007 of the NYSE American Company Guide (the “Company Guide”). The receipt of the Delinquency Notification has no immediate effect on the listing or trading of the Company’s common stock on the Exchange. NYSE Regulation informed the Company that, under Exchange rules, the Company has six mon”

UNIVERSAL SAFETY PRODUCTS, INC. received a nyse_american deficiency notice notice regarding late filing (rules 1007).

“nual Report on Form 10-K for the year ended March 31, 2025 with the Securities and Exchange Commission (the “SEC”). The Delinquency Notification also states that the Company’s failure to timely file such Annual Report on Form 10-K subjects the Company to the procedures and requirements set forth in Section 1007 of the NYSE American Company Guide (the “Company Guide”). The receipt of the Delinquency Notification has no immediate effect on the listing or trading of the Company’s common stock on the Exchange. NYSE Regulation informed the Company that, under Exchange rules, the Company has six mon”

Wag! Group Co. received a nasdaq deficiency notice notice regarding market value (rules 5450(b)(3)(C)).

“July 17, 2025, the Company received a written notice from the staff (the “Staff”) of the Listing Qualifications Department of the Nasdaq Stock Market (“Nasdaq”) notifying the Company that it had not regained compliance with Nasdaq Listing Rule 5450(b)(3)(C) related to the market value of its listed securities. Accordingly, the Staff informed the Company that, since it had not regained compliance, the Nasdaq Hearing Panel (the “Panel”) would consider the matter in their decision regarding the Company’s continued listing on Nasdaq and that the Company should present its views with respect to the”

Silexion Therapeutics Corp received a nasdaq deficiency notice notice regarding minimum bid price (rules 5550(a)(2)).

“July 18, 2025, Silexion Therapeutics Corp (the “ Company ” or “ Silexion ”) received a letter from the Listing Qualifications Department (the “ Staff ”) of the Nasdaq Stock Market LLC (“ Nasdaq ”) notifying the Company that, for the 30 consecutive business days preceding the letter, the closing bid price of the Company’s ordinary shares, par value $0.0009 per share (“ ordinary share s”), was below the minimum $1.00 per share required for continued listing on The Nasdaq Stock Market LLC under Nasdaq Listing Rule 5550(a)(2) (the “ bid price deficiency ”). The Staff indicated in the letter that”

AXT INC received a nasdaq noncompliance notice notice regarding audit committee (rules 5605(c)(2)(A), 5605(c)(4)(B)).

“July 14, 2025, the Company notified The Nasdaq Stock Market LLC (“Nasdaq”) that due to Ms. Russell's death, the Company’s Audit Committee has been reduced to two independent directors, and the Company is not compliant with Nasdaq Lising Rule 5605(c)(2)(A), which requires the Audit Committee to be comprised of a minimum of three independent directors. Pursuant to Nasdaq Listing Rule 5605(c)(4)(B), the Company has a cure period to regain compliance until the earlier of the Company’s next annual meeting of stockholders or July 11, 2026. The Company intends to regain compliance as soon as possible”

Neuphoria Therapeutics Inc. received a nasdaq deficiency notice notice regarding other (rules 5620(a)).

“July 18, 2025, Neuphoria Therapeutics Inc. (the “Company”) received a deficiency notification letter (the “ Notice ”) from the Listing Qualifications Staff of The Nasdaq Stock Market LLC (“ Nasdaq ”). The Notice indicated that the Company was not in compliance with Nasdaq Listing Rule 5620(a) (the “ Listing Rule ”) as a result of the Company’s failure to hold an annual meeting of stockholders within twelve months of the end of the Company’s fiscal year ended June 30, 2024. The Listing Rule requires that a Nasdaq-listed company hold an annual meeting of shareholders no later than one year after”

FEMASYS INC received a nasdaq deficiency notice notice regarding minimum bid price (rules 5550(a)(2)).

“July 16, 2025, Femasys Inc. (the “Company”) received a notice from The Nasdaq Stock Market (“Nasdaq”) that the Company is not in compliance with Nasdaq’s Listing Rule 5550(a)(2), as the minimum bid price of the Company’s common stock has been below $1.00 per share for 30 consecutive business days (the “Minimum Bid Price Requirement”). The notification of noncompliance has no immediate effect on the listing or trading of the Company’s common stock on The Nasdaq Capital Market. The Company has 180 calendar days, or until January 12, 2026, to regain compliance with the Minimum Bid Price Require”

CIMG Inc. received a nasdaq delisting notice notice regarding minimum bid price (rules 5550(a)(2)).

“July 17, 2025, CIMG Inc. (Nasdaq: IMG) (the “Company”) received an additional delist determination letter from Nasdaq (“Nasdaq Delist Determination Letter”). On January 14, 2025, Nasdaq notified the Company that the bid price of its listed security had closed at less than $1 per share over the previous 30 consecutive business days, and, as a result, did not comply with Listing Rule 5550(a)(2) (the “Rule”). In accordance with Listing Rule 5810(c)(3)(A), the Company was provided 180 calendar days, or until July 14, 2025, to regain compliance with the Rule. The Company has not regained compliance”

Beneficient received a nasdaq delisting notice notice regarding late filing (rules 5250(c)(1)).

“ny has not yet filed its Annual Report on Form 10-K for the fiscal year ending March 31, 2025 with the Securities and Exchange Commission and, as such, the Determination Letter also notified the Company that its non-compliance with the periodic reporting requirement set forth in Nasdaq Listing Rule 5250(c)(1) (the “ Filing Requirement ”) could serve as a separate and additional basis for delisting. In addition to the Company’s request for a hearing before the Panel and in accordance with Nasdaq Listing Rule 5815(a)(1), the Company also plans to timely submit a request for a further extension o”

Beneficient received a nasdaq delisting notice notice regarding minimum bid price (rules 5550(a)(2)).

“ny has not yet filed its Annual Report on Form 10-K for the fiscal year ending March 31, 2025 with the Securities and Exchange Commission and, as such, the Determination Letter also notified the Company that its non-compliance with the periodic reporting requirement set forth in Nasdaq Listing Rule 5250(c)(1) (the “ Filing Requirement ”) could serve as a separate and additional basis for delisting. In addition to the Company’s request for a hearing before the Panel and in accordance with Nasdaq Listing Rule 5815(a)(1), the Company also plans to timely submit a request for a further extension o”

SOCIETY PASS INCORPORATED. received a nasdaq noncompliance notice notice regarding stockholders equity (rules 5550(b)(2)).

“February 27, 2025 unless the Company timely requested an appeal of this determination before the Nasdaq Hearings Panel (the “Panel”). The Company timely requested a hearing (the “Hearing”) before the Panel, which stayed the suspension of the Company’s common stock pending the Panel’s decision, and the Hearing was held on April 1, 2025. On April 9, 2025, the Panel issued a decision that granted the Company’s request to continue its listing on Nasdaq based on the information presented. The Panel has determined to grant the Company’s request for an exception until June 30, 2025. On July 15, 2025”

Greenland Mines Ltd received a nasdaq compliance regained notice regarding stockholders equity (rules 5550(b)(1)).

“July 14, 2025, Klotho Neurosciences, Inc. (the “Company”), received a letter from the Staff of The Nasdaq Stock Market LLC (“Nasdaq”) confirming that the Company has regained compliance with the minimum $1.00 bid price under NASDAQ Listing Rule 5550(a)(2), and the minimum stockholders’ equity threshold of $2.5 million under Listing Rule 5550(b)(1). In addition, on July 14. 2025, Nasdaq approved the Company’s application to “phase down” the listing of its common stock and warrants from the Nasdaq Global Market to the Nasdaq Capital Market. The Company’s common stock will continue to trade under”

Greenland Mines Ltd received a nasdaq compliance regained notice regarding minimum bid price (rules 5550(a)(2)).

“July 14, 2025, Klotho Neurosciences, Inc. (the “Company”), received a letter from the Staff of The Nasdaq Stock Market LLC (“Nasdaq”) confirming that the Company has regained compliance with the minimum $1.00 bid price under NASDAQ Listing Rule 5550(a)(2), and the minimum stockholders’ equity threshold of $2.5 million under Listing Rule 5550(b)(1). In addition, on July 14. 2025, Nasdaq approved the Company’s application to “phase down” the listing of its common stock and warrants from the Nasdaq Global Market to the Nasdaq Capital Market. The Company’s common stock will continue to trade under”

Bowen Acquisition Corp received a nasdaq delisting notice notice regarding other (rules 5450(a)(2), 5450(b)(2)(A), 5450(b)(2)(B), 5450(b)(2)(C)).

“July 15, 2025, the Company received a delisting determination letter (the “Delisting Determination Letter”) notifying the Company that its securities are now subject to delisting from the Nasdaq Global Market. The Delisting Determination Letter stated that the Company was not in compliance with (A) Nasdaq Listing Rules 5450(b)(2)(A), which requires companies listed on the Nasdaq Global Market to have Market Value of Listed Securities of at least $50,000,000 for a period of 30 consecutive trading days, (B) Nasdaq Listing Rules 5450(b)(2)(B), which requires that companies listed on the Nasdaq Gl”

BRAINSTORM CELL THERAPEUTICS INC. received a nasdaq delisting notice notice regarding stockholders equity (rules 5550(b)(1)).

“July 16, 2025, Brainstorm Cell Therapeutics Inc. (the “ Company ”) was notified by The Nasdaq Stock Market LLC (“ Nasdaq ”) that as a result of the Company’s previously disclosed noncompliance with Nasdaq Listing Rule 5550(b)(1), Nasdaq has determined to delist the Company’s common stock from the Nasdaq Capital Market and, accordingly, will suspend trading in the Company’s common stock effective at the open of trading on July 18, 2025. The Company has applied and been approved to have its common stock quoted on the OTC Markets’ OTCQB® market tier, an electronic quotation service operated by OT”

Wetouch Technology Inc. received a nasdaq deficiency notice notice regarding minimum bid price (rules 5550(a)(2), 5810(c)(3)(A)).

“July 15, 2025, WETOUCH TECHNOLOGY INC. (the “Company”), received a letter (the “Notice”) from the Listing Qualifications Department (the “Staff”) of The Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that for the last 30 consecutive business days prior to the date of the Notice, the closing bid price of the Company’s securities (the “Bid Price”) was less than $1.00 per share, which does not meet the requirement for continued listing on The Nasdaq Global Market, as required by Nasdaq Listing Rule 5550(a)(2) (the “Bid Price Rule”). In accordance with Nasdaq Listing Rule 5810(c)(3)(A)”

Empery Digital Inc. received a nasdaq delisting notice notice regarding minimum bid price (rules 5550(a)(2)).

“May 13, 2025, the Company received a deficiency letter from the Listing Qualifications Department (the “Staff”) of the Nasdaq Stock Market (“Nasdaq”) notifying the Company that the minimum closing bid price per share for its common stock was below $1.00 for a period of 30 consecutive business days and that the Company did not meet the minimum bid price requirement set forth in Nasdaq Listing Rule 5550(a)(2) (the “Bid Price Rule”).∙ Following a June 24, 2025, hearing with a Nasdaq Hearings Panel (the ”Panel”), the Panel issued its determination, indicating the Company shall demonstrate complian”

ZyVersa Therapeutics, Inc. received a nasdaq delisting notice notice regarding minimum bid price (rules 5550(a)(2)).

“July 15, 2025, ZyVersa Therapeutics, Inc. (the “Company”) received a determination letter (the “Letter”) from The Nasdaq Stock Market LLC (“Nasdaq”) indicating that the Nasdaq Hearings Panel (the “Panel”) has determined to deny the Company’s request to continue its listing on The Nasdaq Capital Market. As previously disclosed, the Nasdaq Listing Qualifications Department (the “Staff”) notified the Company of its determination to delist the Company’s securities because the Company is not in compliance with the minimum bid price requirements under Listing Rule 5550(a)(2), unless the Company requ”

374Water Inc. received a nasdaq extension granted notice regarding minimum bid price (rules 5810(c)(3)(A)(ii)).

“July 15, 2025, the Company received a letter from the Staff advising that the Company had been granted a 180-day extension, or until January 12, 2026, to regain compliance with the Minimum Bid Price Requirement, in accordance with Nasdaq Listing Rule 5810(c)(3)(A)(ii). The Company intends to continue actively monitoring the closing bid price of its common stock and may, if appropriate, consider available options to regain compliance with the Minimum Bid Price Requirement. To regain compliance, the Company’s common stock must have a closing bid price of at least $1.00 per share for a minimum of”

374Water Inc. received a nasdaq deficiency notice notice regarding minimum bid price (rules 5550(a)(2), 5810(c)(3)(A), 5810(c)(3)(A)(ii)).

“January 15, 2025, 374Water Inc. (the “ Company ”) received a deficiency letter (the “ Notice ”) from the Nasdaq Listing Qualifications Department (the “ Staff ”) of the Nasdaq Stock Market LLC (“ Nasdaq ”) notifying the Company that because the closing bid price for the Company’s common stock listed on Nasdaq was below $1.00 for 30 consecutive trading days, the Company was not in compliance with the minimum bid price requirement for continued listing on The Nasdaq Capital Market pursuant to Nasdaq Listing Rule 5550(a)(2) (the “ Minimum Bid Price Requirement ”). In accordance with Nasdaq Listin”

AIRWA INC. received a nasdaq deficiency notice notice regarding board independence (rules 5605, 5605(b)(1)(A), 5605(c)(4)).

“July 9, 2025, Connexa Sports Technologies Inc. (the “ Company ”) received a letter (the “ Notice ”) from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“ Nasdaq ”) indicating that, as a result of Warren Andrew Thomson’s resignation from the Board of Directors of the Company (the “ Board ”) and the audit committee of the Board (the “ Audit Committee ”), effective June 12, 2025, the Company is not currently in compliance with Nasdaq Listing Rule 5605. The Notice has no immediate effect on the listing or trading of the Company’s common stock. Nasdaq Listing Rule 5605 requir”

BONK, INC. received a nasdaq extension granted notice regarding minimum bid price (rules 5550(a)(2)).

“isting Rule 5550(a)(2) (“Rule 5550(a)(2)”). Nasdaq’s Notice has no immediate effect on the listing or trading of our”

BONK, INC. received a nasdaq deficiency notice notice regarding minimum bid price (rules 5550(a)(2)).

“January 2, 2025, Safety Shot, Inc., (the “Company”) received a notice from The Nasdaq Stock Exchange (“Nasdaq”) that the closing bid price for our common stock had been below $1.00 per share for the previous 30 consecutive days, and that we are therefore not in compliance with the minimum bid price requirement for continued inclusion on The Nasdaq Capital Market under Nasdaq Listing Rule 5550(a)(2) (“Rule 5550(a)(2)”). Nasdaq’s Notice has no immediate effect on the listing or trading of our common stock on the Nasdaq Capital Market. On July 9, 2025, the Company received a notification (the “Ex”

ALPHA MODUS HOLDINGS, INC. received a nasdaq compliance regained notice regarding market value (rules 5450(b)(2)(C), 5450(b)(2)(A)).

“July 14, 2025, the listings of the Class A common stock and warrants of Alpha Modus Holdings, Inc. (the “ Company ”) were transferred to The Nasdaq Capital Market (the “ Nasdaq Capital Market ”). The transfer of the Company’s listings to the Nasdaq Capital Market from the Nasdaq Global Market resolves (i) the Company’s Market Value of Publicly Held Shares deficiency under Nasdaq Listing Rule 5450(b)(2)(C), and Nasdaq’s related notice dated January 6, 2025 (as disclosed in the Company’s Current Report on Form 8-K filed on January 10, 2025), and (ii) the Company’s Market Value of Listed Securiti”

Solo Brands, Inc. received a nyse compliance regained notice regarding other (rules 802.01D).

“July 14, 2025, the New York Stock Exchange (the “NYSE”) notified Solo Brands, Inc. (the “Company”) that the NYSE has withdrawn its delisting determination and will be lifting the trading suspension of the Company’s Class A common stock on the NYSE. The staff of NYSE Regulation determined that the Company had regained compliance with Rule 802.01D of the NYSE Listed Company Manual due to the Class A common stock trading above “abnormally low price” levels; and Rule 802.01D of the NYSE Listed Company Manual due to the Company maintaining an average global market capitalization over a consecutive”

ScanTech AI Systems Inc. received a nasdaq deficiency notice notice regarding minimum bid price (rules 5450(a)(1)).

“July 10, 2025, ScanTech AI Systems Inc. (the “Company”) received a written notice (the “Notice”) from the Listing Qualifications Department of The Nasdaq Stock Market (“Nasdaq”) indicating that the Company is not in compliance with the $1.00 minimum bid price requirement set forth in Nasdaq Listing Rule 5450(a)(1) (the “Bid Price Requirement”) for continued listing on The Nasdaq Global Market. The Nasdaq Listing Rules require listed securities to maintain a minimum bid price of $1.00 per share, and, based upon the closing bid price of the Company’s common stock for the 30 consecutive business”

OLENOX INDUSTRIES INC. received a nasdaq hearing update notice regarding minimum bid price (rules 5550(a)(2)).

“July 8, 2025, Safe & Green Holdings Corp. (the “Company”) received a decision letter from the Nasdaq Hearings Panel (the “Panel”) granting the Company’s request for continued listing on the Nasdaq Capital Market. The decision is conditioned on the Company maintaining full compliance with all continued listing requirements of the Nasdaq Capital Market by August 28, 2025. On or before August 28, 2025, the Company must effect a reverse stock split and demonstrate compliance with Nasdaq Listing Rule 5550(a)(2) by achieving a closing bid price of $1.00 or more per share for at least ten (10) consec”

Lunai Bioworks Inc. received a nasdaq deficiency notice notice regarding shareholders (rules 5620(a), 5810(c)(2)(G)).

“July 7, 2025, Renovaro Inc. (the “Company”) received a written notice (the “Notice”) from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that it is no longer in compliance with Nasdaq Listing Rule 5620(a), which requires that listed companies hold an annual meeting of shareholders no later than one year after the end of their fiscal year. The Company did not hold its annual meeting of shareholders within twelve months of the end of its fiscal year ended June 30, 2024, and therefore did not satisfy this requirement. Pursuant to Nasdaq Listi”

Imunon, Inc. received a nasdaq extension granted notice regarding minimum bid price (rules 5505(b), 5550(b)(1), 5810(d)(2)).

“July 11, 2025, the Panel notified the Company that it has granted Company’s request for an exception (the “Exception”) tailored to the time needed for the Company to regain compliance with the Minimum Bid Price Requirement and the Minimum Stockholders’ Equity Requirement. Pursuant to the Exception, the Company is required to provide the Panel with prompt notification of any significant events that occur, including any event that may call into question the Company’s ability to satisfy the terms of the Exception. There can be no assurance that the Company will be able to regain compliance with t”

AgEagle Aerial Systems Inc. received a nyse_american noncompliance notice notice regarding stockholders equity (rules 1003(a)(i), 1003(a)(ii), 1003(a)(iii)).

“April 23, 2025 stating that the Company was not in compliance with the minimum stockholders’ equity requirements of Sections 1003(a)(i), 1003(a)(ii) and 1003(a)(iii) (collectively, the “Listing Rules”) of the NYSE American Company Guide (the “Company Guide”) requiring stockholders’ equity of (i) $2.0 million or more if the Company has reported losses from continuing operations and/or net losses in two of its three most recent fiscal years, (ii) $4.0 million or more if the Company has reported losses from continuing operations and/or net losses in three of the four most recent fiscal years and”

DURECT CORP received a nasdaq extension granted notice regarding minimum bid price (rules 5550(a)(2)).

“g the Company that for 30 consecutive trading days preceding the date of the Notice, the bid price of the Company’s common stock had closed below the $1.00 per share minimum required for continued listing on The Nasdaq Capital Market under Nasdaq Listing Rule 5550(a)(2) (the “Minimum Bid Price Requirement”). The Notice stated that the Company had 180 days, or until July 8, 2025, to demonstrate its compliance with the Minimum Bid Price Requirement.”

Axe Compute Inc. received a nasdaq deficiency notice notice regarding minimum bid price (rules 5550(a)(2)).

“July 8, 2025, the Company received a letter from the Listing Qualifications Department (the “Staff”) of The Nasdaq Stock Market LLC (“Nasdaq”) indicating that the bid price for the Company’s common stock had closed below $1.00 per share for 30 consecutive business days, and that the Company is therefore not in compliance with the minimum bid price requirement for continued listing on The Nasdaq Capital Market under Nasdaq Marketplace Rule 5550(a)(2) (the “Minimum Bid Price Requirement”). The notification has no immediate effect on the listing of the Company’s common stock. The Company has a pe”

Corvex, Inc. received a nasdaq delisting notice notice regarding minimum bid price (rules 5550(a)(2), 5250(c)(1), 5810(c)(3)(A)(iv)).

“July 7, 2025, Movano Inc. (the “Company”) received a written notice (the “Notice”) from the Listing Qualifications Department of Nasdaq Stock Market (“Nasdaq”) indicating that, because the closing bid price for the Company’s common stock has fallen below $1.00 per share for 30 consecutive trading days, the Company was no longer in compliance with the $1.00 Minimum Bid Price requirement set forth in Nasdaq Listing Rule 5550(a)(2) for continued listing on The Nasdaq Capital Market (the “Bid Price Requirement”) and the late filing requirement, as set forth in Listing Rule 5250(c)(1), given the de”

Vicarious Surgical Inc. received a nyse noncompliance notice notice regarding market value (rules 802.01B).

“April 10, 2025, Vicarious Surgical Inc. (the “Company”) received a written notice (the “Notice”) from the New York Stock Exchange (the “NYSE”) indicating the Company was no longer in compliance with the NYSE’s continued listing standards set forth in Section 802.01B of the NYSE’s Listed Company Manual (the “Minimum Market Capitalization Standard”) due to the fact that the Company’s average global market capitalization over a consecutive 30 trading-day period was less than $50 million and, at the same time, its stockholders’ equity was less than $50 million. In accordance with applicable NYSE p”

Bark, Inc. received a nyse deficiency notice notice regarding minimum bid price (rules 802.01C).

“July 10, 2025, BARK, Inc. (the “Company”) received written notice (the “Notice”) from the New York Stock Exchange (the “NYSE”) that it is not in compliance with the continued listing standard set forth in Section 802.01C of the NYSE’s Listed Company Manual (“Section 802.01C”) because the average closing price of the Company’s common stock was less than $1.00 per share over a consecutive 30 trading-day period ended July 9, 2025. The Notice does not result in the immediate delisting of the Company’s common stock from the NYSE. In accordance with applicable NYSE rules, the Company has notified NY”

Maison Solutions Inc. received a nasdaq noncompliance notice notice regarding minimum bid price (rules 5550(a)(2)).

“July 10, 2025, Maison Solutions Inc. (the “Company”) received a letter (the “Nasdaq Staff Deficiency Letter”) from The Nasdaq Stock Market LLC (“Nasdaq”) indicating that, for the last 30 consecutive business days, the bid price for the Company’s common stock had closed below the minimum $1.00 per share requirement for continued listing on The Nasdaq Capital Market under Nasdaq Listing Rule 5550(a)(2) (the “Minimum Bid Price Requirement”). In accordance with Nasdaq Listing Rule 5810(c)(3)(A), the Company has been provided an initial period of 180 calendar days, or until January 6, 2026, to rega”

Bowen Acquisition Corp received a nasdaq deficiency notice notice regarding other (rules 5450(b)(2)(B)).

“July 10, 2025, Bowen Acquisition Corp (the “Company”) received a notice from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”) stating that the Company failed to maintain a minimum of 1,100,000 publicly held shares as required for continued listing on the Nasdaq Global Market under Nasdaq Listing Rule 5450(b)(2)(B). The Notice stated that no later than August 25, 2025, the Company is required to submit a plan to regain compliance with the above referenced rule. If NASDAQ accepts the Company’s plan, it has the discretion to grant the Company an extension of up to 1”

ALPHATIME ACQUISITION CORP received a nasdaq compliance regained notice regarding other (rules 5450(a)(2)).

“received a letter from Nasdaq confirming that the Company has regained compliance with Listing Rule 5450(a)(2) since Nasdaq approved the transfer to the Nasdaq Capital Market. The Nasdaq Capital Market is one of the three market tiers for Nasdaq-listed stock and is a continuous trading market that operates in substantially the same manner as the Nasdaq Global Market. The Securities will continue to trade under the symbols “ATMC,” “ATMCU,” ‘ATMCW” and “ATMCR” and the Company does not expect the transfer to the Nasdaq Capital Market to have any material impact on the trading of its Securities.”

MacKenzie Realty Capital, Inc. received a nasdaq deficiency notice notice regarding minimum bid price (rules 5550(a)(2), 5810(c)(3)(A)).

“July 7, 2025, MacKenzie Realty Capital, Inc. (the “Company”) received a letter (the “Bid Price Deficiency Notice”) from the listing qualifications department staff of The Nasdaq Stock Market (“Nasdaq”) indicating that the Company is not in compliance with the $1.00 minimum bid price requirement set forth in Nasdaq Listing Rule 5550(a)(2) for continued listing on The Nasdaq Capital Market (the “Bid Price Requirement”). The Bid Price Deficiency Notice has no immediate effect on the listing of the Company’s common stock, and the Company’s common stock continues to trade on the Nasdaq Capital M”

Sensei Biotherapeutics, Inc. received a nasdaq compliance regained notice regarding minimum bid price (rules 5550(a)(2)).

“July 2, 2025, Sensei Biotherapeutics, Inc. (the “Company”) received a letter from the Listing Qualifications Staff (the “Staff”) of The Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that the Staff has determined that for 10 consecutive business days, from June 17, 2025 to July 1, 2025, the closing bid price of the Company’s common stock has been at $1.00 per share or greater. Accordingly, the Staff has determined that the Company has regained compliance with Nasdaq Listing Rule 5550(a)(2). 2 SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registra”

TREASURE GLOBAL INC received a nasdaq deficiency notice notice regarding other (rules 5620(a), 5810(c)(2)(G), 5815(a)).

“July 2, 2025, Treasure Global Inc (the “Company”) received a notification letter (the “Notification Letter”) from the Listing Qualifications Department (the “Staff”) of the Nasdaq Stock Market LLC (“Nasdaq”) indicating the Company’s failure to satisfy a continued listing standard from Nasdaq under Listing Rule 5620(a). The Notification Letter indicated that the Company failed to hold an annual meeting of stockholders within the required twelve-month period from the end of the Company’s fiscal year. The Notification Letter is only a notification of deficiency, not of imminent delisting. Therefo”

PALATIN TECHNOLOGIES INC received a nyse_american delisting notice notice regarding other (rules 1003(a), 1003(f)(v)).

“July 7, 2025, Palatin Technologies, Inc. (the “Company”) received written notification from NYSE American LLC (“NYSE American” or the “Exchange”) stating that a Listing Qualifications Panel (the “Panel”) of the Exchange’s Committee for Review (the “Committee for Review”) had unanimously determined to affirm the decision of the staff of NYSE American to initiate delisting proceedings of the Company’s common stock pursuant to Sections 1003(a) and 1003(f)(v) of the NYSE American Company Guide. A hearing on the proposed delisting was held before the Panel on June 18, 2025. The Company intends to”